Kenneth Ataga, Biree Andemariam, David Rees, Hailing Guo, Ahmed Daak. "A randomized, double-blind, placebo-controlled trial of a novel BTK inhibitor (rilzabrutinib) in patients with sickle cell disease (SCD) aged 10–65 years: LIBRA Study." Blood, 2025. doi:10.1182/blood-2025-2975